Molecular heterogeneity of head and neck squamous cell carcinoma defined by next-generation sequencing

American Journal of Pathology

Volumn 184, Issue 5, 2014, Pages 1323-1330

  Zhang, Pan ^a   Mirani, Neena ^a   Baisre, Ada ^a   Fernandes, Helen ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; ATM PROTEIN; CD135 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; NOTCH1 RECEPTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN P53; PROTEIN RET; PROTEIN TYROSINE PHOSPHATASE SHP 2; RETINOBLASTOMA BINDING PROTEIN 1; SCATTER FACTOR RECEPTOR; SMAD4 PROTEIN; SMOOTHENED PROTEIN; TYROSINE KINASE RECEPTOR; VASCULOTROPIN RECEPTOR 2; P16 PROTEIN, HUMAN; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROTEIN;

ABL1 GENE; AKT1 GENE; APC GENE; ARTICLE; ATM GENE; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; CSF1R GENE; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; FBXW7 GENE; FEMALE; FIBROBLAST GROWTH FACTOR RECEPTOR 3 GENE; FLT3 GENE; GENE P53; GENETIC HETEROGENEITY; GENETIC PROCEDURES; GENETIC VARIABILITY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEPATOCYTE NUCLEAR FACTOR 1ALPHA GENE; HUMAN; HUMAN TISSUE; KIT GENE; MAJOR CLINICAL STUDY; MALE; MET GENE; MOLECULAR PATHOLOGY; NEXT GENERATION SEQUENCING; NOTCH1 RECEPTOR GENE; ONCOGENE; ONCOGENE K RAS; ONCOGENE N RAS; ONCOGENE RET; PAPILLOMAVIRUS INFECTION; PHOSPHATIDYLINOSITOL 3 KINASE CATALYTIC SUBUNIT ALPHA GENE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR GENE; PRIORITY JOURNAL; PROTEIN TYROSINE PHOSPHATASE SHP 2 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMAD4 GENE; SMOOTHENED GENE; TUMOR SUPPRESSOR GENE; VASCULOTROPIN RECEPTOR 2 GENE; ADULT; ALLELE; BIOLOGICAL MODEL; CASE CONTROL STUDY; DEMOGRAPHY; DNA SEQUENCE; GENETICS; GERMLINE MUTATION; HEAD AND NECK TUMOR; HUMAN GENOME; PROCEDURES; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; VIROLOGY;

ADULT; ALLELES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; GENETIC HETEROGENEITY; GENOME, HUMAN; GERM-LINE MUTATION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899535760     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.01.028     Document Type: Article

References (37)

1. C.R. Leemans, B.J. Braakhuis, and R.H. Brakenhoff The molecular biology of head and neck cancer Nat Rev Cancer 11 2011 9 22
2. D.P. Zandberg, R. Bhargava, S. Badin, and K.J. Cullen The role of human papillomavirus in nongenital cancers CA Cancer J Clin 63 2013 57 81
3. P. Morbini, B. Dal Bello, P. Alberizzi, L. Mannarini, N. Mevio, G. Bertino, and M. Benazzo Exfoliated cells of the oral mucosa for HPV typing by SPF10 in head and neck cancer J Virol Methods 186 2012 99 103
4. M.C. de Jong, J. Pramana, J.L. Knegjens, A.J. Balm, M.W. van den Brekel, M. Hauptmann, A.C. Begg, and C.R. Rasch HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors Radiother Oncol 95 2010 365 370
5. G. D'Souza, and A. Dempsey The role of HPV in head and neck cancer and review of the HPV vaccine Prev Med 53 Suppl 1 2011 S5 S11
6. A.R. Kreimer, G.M. Clifford, P. Boyle, and S. Franceschi Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review Cancer Epidemiol Biomarkers Prev 14 2005 467 475
7. A.R. Kreimer, G.M. Clifford, P.J. Snijders, X. Castellsague, C.J. Meijer, M. Pawlita, R. Viscidi, R. Herrero, S. Franceschi International Agency for Research on Cancer (IARC) Multicenter Oral Cancer Study Group HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas Int J Cancer 115 2005 329 332
8. G. D'Souza, A.R. Kreimer, R. Viscidi, M. Pawlita, C. Fakhry, W.M. Koch, W.H. Westra, and M.L. Gillison Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 2007 1944 1956
9. A. Nasman, P. Attner, L. Hammarstedt, J. Du, M. Eriksson, G. Giraud, S. Ahrlund-Richter, L. Marklund, M. Romanitan, D. Lindquist, T. Ramqvist, J. Lindholm, P. Sparen, W. Ye, H. Dahlstrand, E. Munck-Wikland, and T. Dalianis Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125 2009 362 366
10. K.K. Ang, J. Harris, R. Wheeler, R. Weber, D.I. Rosenthal, P.F. Nguyen-Tan, W.H. Westra, C.H. Chung, R.C. Jordan, C. Lu, H. Kim, R. Axelrod, C.C. Silverman, K.P. Redmond, and M.L. Gillison Human papillomavirus and survival of patients with oropharyngeal cancer New Engl J Med 363 2010 24 35
11. F.P. Worden, B. Kumar, J.S. Lee, G.T. Wolf, K.G. Cordell, J.M. Taylor, S.G. Urba, A. Eisbruch, T.N. Teknos, D.B. Chepeha, M.E. Prince, C.I. Tsien, N.J. D'Silva, K. Yang, D.M. Kurnit, H.L. Mason, T.H. Miller, N.E. Wallace, C.R. Bradford, and T.E. Carey Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number J Clin Oncol 26 2008 3138 3146
12. P. Lassen, J.G. Eriksen, S. Hamilton-Dutoit, T. Tramm, J. Alsner, and J. Overgaard Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol 27 2009 1992 1998
13. G.B. van den Broek, M. Wildeman, C.R. Rasch, N. Armstrong, E. Schuuring, A.C. Begg, L.H. Looijenga, R. Scheper, J.E. van der Wal, L. Menkema, P.J. van Diest, A.J. Balm, M.L. van Velthuysen, and M.W. van den Brekel Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation Int J Cancer 124 2009 2643 2650
14. J.W. Rainsbury, W. Ahmed, H.K. Williams, S. Roberts, V. Paleri, and H. Mehanna Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis Head Neck 35 2013 1048 1055
15. P. Lassen, J.G. Eriksen, S. Hamilton-Dutoit, T. Tramm, J. Alsner, J. Overgaard Danish Head and Neck Cancer Group (DAHANCA) HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer Radiother Oncol 94 2010 30 35
16. B. Braakhuis, M. Rietbergen, M. Buijze, P. Snijders, E. Bloemena, R. Brakenhoff, and C. Leemans TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients Oral Dis 2013 [Epub ahead of print] http://dx.doi.org/10.1111/odi.12178
17. M. Lechner, G.M. Frampton, T. Fenton, A. Feber, G. Palmer, A. Jay, N. Pillay, M. Forster, M.T. Cronin, D. Lipson, V.A. Miller, T.A. Brennan, S. Henderson, F. Vaz, P. O'Flynn, N. Kalavrezos, R. Yelensky, S. Beck, P.J. Stephens, and C. Boshoff Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors Genome Med 5 2013 49
18. N. Stransky, A.M. Egloff, A.D. Tward, A.D. Kostic, K. Cibulskis, and A. Sivachenko et al. The mutational landscape of head and neck squamous cell carcinoma Science 333 2011 1157 1160
19. P.E. Gravitt, C. Peyton, C. Wheeler, R. Apple, R. Higuchi, and K.V. Shah Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays J Virol Methods 112 2003 23 33
20. H. Fernandes, B. Koneru, N. Fernandes, M. Hameed, M.C. Cohen, E. Raveche, and S. Cohen Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients Transplantation 73 2002 1886 1891
21. D.J. Conway, M.J. Holland, R.L. Bailey, A.E. Campbell, O.S. Mahdi, R. Jennings, E. Mbena, and D.C. Mabey Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid Infect Immun 65 1997 1003 1006
22. N. Mozzato-Chamay, O.S. Mahdi, O. Jallow, D.C. Mabey, R.L. Bailey, and D.J. Conway Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis-endemic population J Infect Dis 182 2000 1545 1548
23. V.M. Keatings, S.J. Cave, M.J. Henry, K. Morgan, C.M. O'Connor, M.X. FitzGerald, and N. Kalsheker A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD Chest 118 2000 971 975
24. J. Cuenca, M. Cuchacovich, C. Pérez, L. Ferreira, A. Aguirre, I. Schiattino, L. Soto, A. Cruzat, F. Salazar-Onfray, and J.C. Aguillon The -308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis Rheumatology 42 2003 308 313
25. C. Yapijakis, Z. Serefoglou, A. Vylliotis, E. Nkenke, S. Derka, S. Vassiliou, D. Avgoustidis, F.W. Neukam, E. Patsouris, and E. Vairaktaris Association of polymorphisms in tumor necrosis factor alpha and beta genes with increased risk for oral cancer Anticancer Res 29 2009 2379 2386
26. H. Rikiishi Autophagic action of new targeting agents in head and neck oncology Cancer Biol Ther 13 2012 978 991
27. K.R. Singleton, J. Kim, T.K. Hinz, L.A. Marek, M. Casas-Selves, C. Hatheway, A.C. Tan, J. DeGregori, and L.E. Heasley A receptor tyrosine kinase network composed of fibroblast growth factor receptors, epidermal growth factor receptor, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, and hepatocyte growth factor receptor drives growth and survival of head and neck squamous carcinoma cell lines Mol Pharmacol 83 2013 882 893
28. A.K. Murugan, A.K. Munirajan, and N. Tsuchida Ras oncogenes in oral cancer: the past 20 years Oral Oncol 48 2012 383 392
29. E. Bissada, O. Abboud, Z. Abou Chacra, L. Guertin, X. Weng, P.F. Nguyen-Tan, J.C. Tabet, E. Thibaudeau, L. Lambert, M.L. Audet, B. Fortin, and D. Soulieres Prevalence of K-RAS codons 12 and 13 mutations in locally advanced head and neck squamous cell carcinoma and impact on clinical outcomes Int J Otolaryngol 2013 2013 848021
30. T. Suda, T. Hama, S. Kondo, Y. Yuza, M. Yoshikawa, M. Urashima, T. Kato, and H. Moriyama Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma BMC Cancer 12 2012 416
31. L. Du, J. Shen, A. Weems, and S.L. Lu Role of phosphatidylinositol-3- kinase pathway in head and neck squamous cell carcinoma J Oncol 2012 2012 450179
32. N.J. Nelson Genetic events in head and neck squamous cell carcinoma revealed J Natl Cancer Inst 105 2013 1766 1768
33. W. Qiu, F. Schönleben, H.M. Thaker, M. Goggins, and G.H. Su A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma Oncogene 25 2006 2937 2942
34. J.K. Peltonen, K.H. Vähäkangas, H.M. Helppi, R. Bloigu, P. Pääkko, and T. Turpeenniemi-Hujanen Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study Head Neck Oncol 3 2011 20
35. R. Schneider-Stock, C. Boltze, B. Peters, R. Szibor, O. Landt, F. Meyer, and A. Roessner Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer Neoplasia 6 2004 529 535
36. C. Mozet, M. Stoehr, K. Dimitrova, A. Dietz, and G. Wichmann Hedgehog targeting by cyclopamine suppresses head and neck squamous cell carcinoma and enhances chemotherapeutic effects Anticancer Res 33 2013 2415 2424
37. Guerrero-Preston R, Hadar T, Michailidi C, Marchionni L, Koch W, Sidransky D: Integrated genomic and epigenomic deep sequencing analyses reveal head and neck cancer survival disparities associated to alterations in the PAX, NOTCH1 and TP53 pathways. 6th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, Dec. 6-9, 2013, Atlanta GA. Philadelphia, American Association for Cancer Research, 2013, Abstract A87